Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report
1People’s Hospital of Fu Yang No. 63, luci street, yingzhou district, fuyang city, 236000 An Hui, China
DOI: 10.31083/j.ejgo.2020.03.5098 Vol.41,Issue 3,June 2020 pp.473-476
Submitted: 09 December 2018 Accepted: 25 January 2019
Published: 15 June 2020
*Corresponding Author(s): Rui Zhang E-mail: liuguolin2013090@163.com
Mesenchymal tumors are divided into gastrointestinal stromal tumors (GIST) and extra-intestinal tumors (EGIST). They can occur in various parts of the abdominal cavity, including the greater omentum, rectovaginal septum, peritoneum, retroperitoneum and extremely rarely, in the vagina. Vaginal cancer is an uncommon gynecological tumor and recurrent posterior vaginal gastrointestinal stromal tumors are even rarer. Currently, surgical resection is the main treatment method for this disease. With the deepening molecular understanding of gastrointestinal stromal tumors, in particular the role of c-KIT mutations, targeted therapy with Imatinib has been used in the adjuvant setting, achieving good results. We report a recent case of postmenopausal recurrent retrovaginal gastrointestinal stromal tumor, treated at Linquan County Hospital.
Vagina; Gastrointestinal stromal tumor; Menopause; Imatinib
Guolin Liu,Rui Zhang. Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report. European Journal of Gynaecological Oncology. 2020. 41(3);473-476.
[1] Zhang Chuanqi, Chu Xiuming, Zhao Shuhua.: “Postmenopausal women with posterior vaginal wall gastrointestinal stromal tumor: a case”. Chinese J. Gerontol., 2014, 5, 2554.
[2] Srtickland L., Letson G.D., Mmo-Cacho C.A.: “Gastrointestinal stromal tumors”. Cancer Control, 2001, 8, 252.
[3] Zhang W., Peng Z., Xu L.: “Extragastrointestinal stromal tumor arising in the rectovaginal sptum:report of an unusual case with literature review”.Gynecol. Oncol., 2009, 113, 399.
[4] Yang H.J., Kim T.H., Park M.K., Lim C.H., Lee K.H., Kim C.W., et al.: “A case of primary extragastrointestinal stromal tumor presenting as peritoneal dissemination”. Korean J. Gastroenterol., 2010, 56, 319.
[5] Mazur M.T., Clark H.B.: “Gastric stromal tumor: appraisal of histogenesis”. Am. J. Surg. Pathol., 1983, 7, 507.
[6] Demetri G.D., Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., et al..: “Efficacy and safety of imatinib mesylate in advanced gaserointestinal stromal tumors”. N. Engl. J. Med., 2002, 347, 472.
[7] Ren Y., Chen S.S., Qi M.: “A case of external gastrointestinal stromal tumor of the posterior vaginal wall”. Tumor Prev. Treat. Res., 2010, 37, 245.
[8] Tang Z.Y.: “Modern oncology”. 3rd ed. Shanghai: Fudan University Press, 2011.
[9] Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., et al..: “Effect of the tyrosine kinase inhibit or ST I571 in a patient with metastatic gastrointestinal stromal tumor”. N. Eng. J. Med., 2001, 344, 1052.
[10] Essat M., Cooper K.: “Imatinib as adjuvant therapy for gastrintestinal stromal tumours:a systematic review”. Int. J. Cancer, 2011, 128, 2202.
[11] Jiang Yimei, Zhao Ren: “Laparoscopic resection of vaginorectal septal gastrointestinal stromal tumor: a case report”. Surg. Theory Prac., 2011, 16, 592.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top